Cancer-Related Fatigue Across Sensory, Behavioral, Cognitive, Affective Domains and HRV metrics: A Prevalence Study

Authors

  • D. J. Tanigaiselvane PhD Scholar, CMJ University, Jorabat, Meghalaya Author
  • Dr. Ravi Shankar Ravi Dean of Allied Health Science, Capital University, Jharkhand Author
  • Dr. Anil Kumar Singh Specialist Physiotherapist, Ministry of Health Author

DOI:

https://doi.org/10.29070/sd9zwm05

Keywords:

Cancer-related fatigue, Revised Piper Fatigue Scale, Sensory fatigue, Heart rate Variability (HRV) post-chemotherapy fatigue, Quality of Life

Abstract

Background/Objective: Cancer-related fatigue (CRF) is a multidimensional symptom impacting physical, cognitive, behavioral, and emotional domains. This study evaluates the prevalence of CRF using the Revised Piper Fatigue Scale (PFS-R) across sensory, behavioral, cognitive, and affective domains and Heart rate variability (HRV) among cancer patients’ post-chemotherapy.

Methods: A cross-sectional prevalence study was conducted among 253 post-chemotherapy cancer patients. Demographic data, fatigue severity (assessed using PFS-R and Brief Fatigue Inventory), and biometric measures (HRV) were analyzed.

Results: The sample consisted of 57.3% males and 42.7% females. Fatigue was most prevalent in the 50–60 age group (34.4%). Lung cancer patients reported the highest fatigue levels (BFI: 8.31 ± 0.88), and breast cancer patients the lowest (BFI: 8.06 ± 0.95). Sensory fatigue was the highest domain-specific score (7.85 ± 1.12). Gender and age showed minimal variation.

Conclusion: CRF is highly prevalent among cancer patients, particularly in lung cancer cases. These findings emphasize the importance of comprehensive fatigue management strategies to improve quality of life.

Downloads

Download data is not yet available.

References

Aaronson, N. K., Ahmedzai, S., & Bergman, B. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376. https://doi.org/10.1093/jnci/85.5.365

Bower, J. E. (2014). Cancer-related fatigue-Mechanisms, risk factors, and treatments. Nature Reviews Clinical Oncology, 11(10), 597–609. https://doi.org/10.1038/nrclinonc.2014.127

Benedict, C., et al. (2016). Affective and sensory fatigue domains in cancer patients: A comprehensive review. Journal of Clinical Oncology, 34(5), 341-349. https://doi.org/10.1200/JCO.2015.63.5432

Butt, Z., Rosenbloom, S. K., Abernethy, A. P., Beaumont, J. L., Paul, D., Hampton, D., & Cella, D. (2008). Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy. Journal of the National Comprehensive Cancer Network, 6(5), 448–455. https://doi.org/10.6004/jnccn.2008.0034

Cella, D., et al. (2003). Fatigue in cancer patients: A longitudinal perspective. Cancer, 97(4), 958-965. https://doi.org/10.1002/cncr.11180

Curt, G. A., Breitbart, W., Cella, D., Groopman, J. E., Horning, S. J., Itri, L. M., & Vogelzang, N. J. (2000). Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition. The Oncologist, 5(5), 353–360. https://doi.org/10.1634/theoncologist.5-5-353

Das, S., & Bhowmick, A. (2018). A cross-sectional study on the prevalence and impact of fatigue in breast cancer patients undergoing chemotherapy in an Indian tertiary care hospital. South Asian Journal of Cancer, 7(4), 223–227. https://doi.org/10.4103/sajc.sajc_115_18

Feng, W., et al. (2020). Gender differences in cancer-related fatigue and interventions: A systematic review. International Journal of Cancer Care, 26(3), 235-247. https://doi.org/10.1002/ijc.33052

Gupta, D., Lis, C. G., & Grutsch, J. F. (2007). Perceived cancer-related fatigue: Indian experience. Supportive Care in Cancer, 15(10), 1203–1209. https://doi.org/10.1007/s00520-007-0252-8

Kulkarni, S. P., & Biswas, B. (2016). Cancer-related fatigue in Indian cancer survivors: Prevalence, patterns, and coping strategies. Asian Pacific Journal of Cancer Prevention, 17(3), 1243–1249. https://doi.org/10.7314/APJCP.2016.17.3.1243

Lawrence, D. P., Kupelnick, B., Miller, K., Devine, D., & Lau, J. (2004). Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. Journal of the National Cancer Institute Monographs, 32, 40–50. https://doi.org/10.1093/jncimonographs/lgh027

Minton, O., Stone, P., Richardson, A., Sharpe, M., & Hotopf, M. (2008). A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Annals of Oncology, 19(5), 711–719. https://doi.org/10.1093/annonc/mdm525

Mishra, S. K., & Mohapatra, A. (2015). Cancer-related fatigue in breast cancer survivors: A review of Indian studies. Indian Journal of Palliative Care, 21(3), 282–288. https://doi.org/10.4103/0973-1075.164893

Mishra, S. I., et al. (2012). Age and gender differences in cancer-related fatigue. Supportive Care in Cancer, 20(11), 2679-2687. https://doi.org/10.1007/s00520-012-1413-5

Nayak, M. G., George, A., & Pradhan, N. (2018). Quality of life and fatigue levels among cancer patients in India. Indian Journal of Palliative Care, 24(2), 166–171. https://doi.org/10.4103/IJPC.IJPC_4_18

Palesh, O. G., et al. (2017). Interventions for cancer-related fatigue. Journal of Pain and Symptom Management, 53(4), 746-758. https://doi.org/10.1016/j.jpainsymman.2016.10.371

Pinnell, T. K., et al. (2020). Autonomic dysfunction in cancer patients and its relationship to fatigue. Clinical Autonomic Research, 30(3), 147-155. https://doi.org/10.1007/s10286-020-00706-7

Prasad, R., & Grover, S. (2016). Prevalence of fatigue and its correlates in Indian cancer patients. Indian Journal of Cancer, 53(4), 493–499. https://doi.org/10.4103/ijc.IJC_5_16

Reid, M., et al. (2015). Exercise interventions for fatigue in cancer survivors. Journal of Cancer Survivorship, 9(1), 81-91. https://doi.org/10.1007/s11764-014-0382-x

Stone, P., Richardson, A., Ream, E., Smith, A. G., Kerr, D. J., & Kearney, N. (2000). Cancer-related fatigue: Inevitable, unimportant, and untreatable? Annals of Oncology, 11(8), 971–975. https://doi.org/10.1023/A:1008321301923

Downloads

Published

2024-03-01